Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06383858
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2024-04-14
Brief Title:
The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center
Sponsor:
Organization:
The Third Affiliated Hospital of Guangzhou Medical University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
All enrolled pregnant women will have 5 ml of peripheral blood drawn to detect PIGF levels when enrolling Those with a high risk of preeclampsia need routine monitoring of PlGF or Soluble fms-Like Tyrosine Kinase 1sFlt-1PlGF at 20-246 weeks and 30-306 weeks of pregnancy
Enrollment Count:
50000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 106316 |
Who Masked List: